Global Trust Asset Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History
Global Trust Asset Management, LLC
- $257 Million
- Q4 2024
A detailed history of Global Trust Asset Management, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Global Trust Asset Management, LLC holds 122 shares of ALNY stock, worth $31,286. This represents 0.01% of its overall portfolio holdings.
Number of Shares
122
Previous 122
-0.0%
Holding current value
$31,286
Previous $33,000
15.15%
% of portfolio
0.01%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding ALNY
# of Institutions
669Shares Held
112MCall Options Held
866KPut Options Held
799K-
Capital World Investors Los Angeles, CA16.6MShares$4.26 Billion0.62% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.7MShares$3.27 Billion0.05% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.45 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA6.97MShares$1.79 Billion0.35% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.12 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $31.6B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...